TP53 gene expression in HPV-positive oral tongue SCC and its correlation with nodal metastasis

Pathology Research and Practice

Volumn 207, Issue 12, 2011, Pages 758-761

  Seraj, Jalal Mehdizadeh ^a   Yazdani, Nasrin ^a   Ashtiani, Zahra Ousati ^a   Seraj, Siamak Mehdizadeh ^a   Hasheminasab, Sayed Mohammad ^a   Memar, Bahram ^b   Mirashrafi, Fatemeh ^a   Borghei, Hasti ^a   Yazdani, Javad ^a   Mostaan, Leila Vazifeh ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cervical lymph node metastasis; HPV; Tongue SCC; TP53

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER TISSUE; CERVICAL LYMPH NODE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; SQUAMOUS CELL CARCINOMA; TISSUE FIXATION; TONGUE CARCINOMA; TP53 GENE; TUMOR DIFFERENTIATION; VIRUS CARCINOGENESIS; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION; GENES, P53; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; TONGUE NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 82655184151     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.09.013     Document Type: Article

References (19)

1. Brachman D.G., Graves D., Yokes E., et al. Occurrence of p53 gene deletions and human papillomavirus infection in human head and neck cancer. Cancer Res. 1992, 17:4832-4836.
2. Campisi G., Giovannelli L., Calvino F., et al. HPV infection in relation to OSCC histological grading and TNM stage. Evaluation by traditional statistics and fuzzy logic model. Oral Oncol. 2006, 6:638-645.
3. Chen X., Sturgis E.M., Wei Q., et al. Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers. Carcinogenesis 2008, 11:2120-2125.
4. Dahlgren L., Dahlstrand H.M., Lindquist D., et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int. J. Cancer 2004, 6:1015-1019.
5. Dahlstrom K.R., Adler-Storthz K., Etzel C.J., et al. Human papillomavirus type 16 Infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin. Cancer Res. 2003, 7:2620-2626.
6. da Silva C.E., da Silva I.D., Cerri A., et al. Prevalence of human papillomavirus in squamous cell carcinoma of the tongue. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2007, 4:497-500.
7. Elamin F., Steingrimsdottir H., Wanakulasuriya S., et al. Prevalence of human papillomavirus infection in premalignant and malignant lesions of the oral cavity in U.K. subjects: a novel method of detection. Oral Oncol. 1998, 3:191-197.
8. Hamarstedt L., Lindquist D., Dahlstrand H., et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int. J. Cancer 2006, 11:2620-2623.
9. Ji X., Neumann A.S., Sturgis E.M., et al. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers. Carcinogenesis 2008, 4:875-879.
10. Kantola S., Parikka M., Jokinen K., et al. Prognostic factors in tongue cancer-relative importance of demographic, clinical and histopathological factors. Br. J. Cancer 2000, 5:614-619.
11. Kumar R.V., Kadkol S.S., Daniel R., et al. Human papillomavirus, p53 and cyclin D1 expression in oropharyngeal carcinoma. Int. J. Oral Maxillofac. Surg. 2003, 5:539-543.
12. Lindquist D., Roanitan M., Hammarstedt L., et al. Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol. Oncol. 2007, 350-355.
13. Mukhopadhyay D., Chatterjee R., Chakraborty R.N. Association of p53 expression with cytokinetics and HPV capsid antigen prevalence in oral carcinomas. Cancer Lett. 1994, 1:99-105.
14. Ocadiz-Delgado R., Marroquin A., Hernandez-Mote R., et al. Induction of focal epithelial hyperplasia in tongue of young bk6-E6/E7 HPV16 transgenic mice. Transgenic Res. 2009, 18:513-527.
15. Shiboski C.H., Schmit B.L., Jordan R.C. Tongue and tonsil carcinoma increasing trends in the U.S Population ages 20-44 years. Cancer 2005, 103:1843-1849.
16. Siebers T.J., Merkx M.A., Slootweg P.J., et al. No high-risk HPV detected in SCC of the oral tongue in the absolute absence of tobacco and alcohol-a case study of seven patients. Oral Maxillofac. Surg. 2008, 12:185-188.
17. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J. Clin. Virol. 2005, 32S:59-61.
18. Tasantoulis P.K., Kastrinakis N.G., Tourvas A.D., et al. Advances in the biology of oral cancer. Oral Oncol. 2007, 43:523-534.
19. Parkin M.D., Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 2006, 24s3:11-25.